Related Experiment Video
Updated: May 26, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
[Albuminuria : prognostic marker or therapeutic goal?]
C Chatzikyrkou1, H Haller, J Menne
1Abteilung für Nieren und Hochdruckerkrankungen, Medizinische Hochschule Hannover, Hannover, Deutschland.
Abstract:
Microalbuminuria has most often been linked with renal disease in diabetic patients. However, accumulating data demonstrate that the development of albuminuria is closely associated with cardiovascular and renal disease in both diabetic and non-diabetic patients. The role of albuminuria in the pathogenesis of these clinical conditions remains controversial. While reductions in albuminuria have been associated with improved outcomes, the evidence for lower levels of albuminuria (microalbuminuria and normoalbuminuria) is inconclusive. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have demonstrated some success in treating or delaying the onset of microalbuminuria. However, it remains to be established whether these effects result in meaningful reductions in clinical renal or cardiovascular events.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Diabetic Nephropathy
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome III : Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrotic Syndrome I : Introduction
